Skip to main content
Log in

Dietary G-rutin suppresses glycation in tissue proteins of streptozotocin-induced diabetic rats

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The present study focused on examining the efficacy of feeding a rutin-glucose derivative (G-rutin) to inhibit glycation reactions that can occur in muscle, kidney and plasma proteins of diabetic rats. Both thiobarbituric acid-reactive substance levels and protein carbonyl contents in muscle and kidney were significantly (p < 0.05) reduced in streptozotocin-induced diabetic rats fed G-rutin supplemented diet, compared to diabetic rats fed control diet. The N ε-fructoselysine content in muscle and kidney, a biomarker of early glycation reaction, was markedly (p < 0.05) increased by diabetes, but significantly (p < 0.05) reduced in diabetic rats fed G-rutin. Advanced glycation end-products (AGEs) in serum and kidney protein were measured by immunoblot using anti-AGE antibody, and were also reduced in diabetic rats fed dietary G-rutin. Feeding G-rutin also slightly inhibited aldose reductase activity in these animals. These results demonstrate for the first time that dietary G-rutin consumption can provide potential health benefits that are related to the inhibition of tissue glycation reactions common to diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yaylayan VA, Huyghues-Despointes A: Chemistry of Amadori rearrangement products: Analysis, synthesis, kinetics, reaction and spectroscopic properties. Crit Rev Food Sci Nutr 34: 321-369, 1994

    Google Scholar 

  2. Chellan P, Nagaraj RH: Protein crosslinking by the Maillard reaction: Dicarbonyl-derived imidazolium crosslinks in aging and diabetes. Arch Biochem Biophys 368: 98-104, 1990

    Google Scholar 

  3. Brownlee M: Advanced protein glycation in diabetes and aging. Annu Rev Med 46: 223-234, 1995

    Google Scholar 

  4. Odetti PR, Borgoglio A, De Pascale A, Rolaandi R, Adezati L: Prevention of diabetes-increased aging effect on rat collagen linked fluorescence by aminoguanidine and rutin. Diabetes 39: 796-801, 1990

    Google Scholar 

  5. Watanabe H, Ogasawara M, Suzuki N, Nishizawa N, Ambo K: Glycation of myofibrillar protein in aged rats and mice. Biosci Biotechnol Biochem 56: 1109-1112 1992

    Google Scholar 

  6. Ryle C, Leow CK, Donaghy M: Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus. Muscle Nerve 20: 577-584 1997

    Google Scholar 

  7. Schleicher ED, Wagner E, Nerlich AG: Increase accumulation of the glycoxidation product N ε-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 99: 457-468, 1997

    Google Scholar 

  8. Frye EB, Degenhardt TP, Thorpe SR, Baynes JW: Role of the Maillard reaction in aging of tissue proteins. J Biol Chem 273: 18714-18719, 1998

    Google Scholar 

  9. Manuel Y, Keenoy B, Vertommen J, De Leeuw I: The effect of flavonoid treatment on the glycation and antioxidant status in type 1 diabetic patients. Diab Nutr Metab 12: 256-263, 1999

    Google Scholar 

  10. Verzijl N, DeGroot J, Oldehinkel E, Bank RA, Thorpe SR, Baynes JW, Bayliss MT, Brjlsma JWJ, Lafeber FPJG, TeKoppele JM: Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J 350: 381-387, 2000

    Google Scholar 

  11. Singh R, Barden A, Mori T, Beilin L: Advanced glycation end-products: A review. Diabetologia 44: 129-146, 2001

    Google Scholar 

  12. Dosquet OCC, Wautier M-P, Wautier J-L: Advanced glycation end products, oxidant stress and vascular lesions. Eur J Clin Invest 27: 97-108, 1997

    Google Scholar 

  13. Sima AA, Sugimoto K: Experimental diabetic neuropathy: An update. Diabetologia 42: 773-788, 1999

    Google Scholar 

  14. Miyata T, Saito A, Kurokawa K, Van Upersele de Strihou C: Advanced glycation and lipoxidation end products: Reactive carbonyl compounds-related uremic toxicity. Nephrol Dial Transplant 16(suppl 4): 8-11, 2001

    Google Scholar 

  15. Kakkar R, Mantha SV, Radhi J, Prasad K, Kalra J: Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clin Sci 94: 623-632, 1998

    Google Scholar 

  16. West IC: Radicals and oxidative stress in diabetes. Diabet Med 17: 171-180, 2000

    Google Scholar 

  17. Sharma A, Kharb S, Chugh SN, Kakkar R, Singh GP: Evaluation of oxidative stress before and after vitamin E supplementation in diabetic patients. Metabolism 49: 160-162 2000

    Google Scholar 

  18. Giardino I, Fard AK, Hatchell DL, Brownlee M: Aminoguanidinee inhibits reactive oxygen species formation, lipid peroxidation and oxidant induced apoptosis. Diabetes 47: 1114-1120, 1998

    Google Scholar 

  19. Rice-Evans CA, Moller NJ, Bolwell PG, Bramley PM, Pridham JB: The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res 22: 375-383, 1995

    Google Scholar 

  20. Liao K, Yin M: Individual and combined antioxidant effects of seven phenolic agents in human erythrocyte membrane ghosts and phosphatidylcholine liposome systems: Importance of the partition coefficient. J Agric Food Chem 48: 2266-2270, 2000

    Google Scholar 

  21. Lean MEJ, Noroozi M, Kelly I, Burns J, Talwar D, Sattar N, Crozier A: Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes 48: 176-181, 1999

    Google Scholar 

  22. Asgary S, Naderi G, Sarrafzadegan N, Ghassemi N, Boshtam M, Rafie M, Arefian A: Anti-oxidant effect of flavonoids on hemoglobin glycosylation. Pharm Acta Helv 73: 223-236, 1999

    Google Scholar 

  23. Nagasawa T, Tabata N, Ito Y, Nishizawa N, Aiba Y, Kitts DD: Inhibition of glycation reaction in tissue protein incubations by water soluble rutin derivatives. Mol Cell Biochem (in press)

  24. Suzuki Y, Suzuki K: Enzymatic formation of 4G-α-glucopyranosylrutin. Agric Biol Chem 55: 181-187, 1991

    Google Scholar 

  25. Shimoi K, Shen B, Toyokuni S, Mochizuki R, Furugori M, Kinae N: Protection by αG-rutin, a water-soluble antioxidant flavonoid, against renal damage in mice treated with ferric nitrilotriacetate. Jpn J Cancer Res 88: 453-460, 1997

    Google Scholar 

  26. Funabiki R, Takeshita K, Miura Y, Shibasato M, Nagasawa T: Dietary supplement of G-rutin reduces oxidative damage in the rodent model. J Agric Food Chem 47: 1078-1082, 1999

    Google Scholar 

  27. Waterlow JC, Garlick PJ, Millward DJ: Protein Turnover in Mammalian Tissues and in the Whole Body. North-Holland Publishing Company, Amsterdam, Netherlands, 1978, pp 481-528

    Google Scholar 

  28. Reeves PG, Nielsen FH, Fahey GC Jr: AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951, 1993

    Google Scholar 

  29. Uchiyama M, Mihara M: Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86: 271-278, 1978

    Google Scholar 

  30. Nagasawa T, Hatayama T, Watanabe Y, Tanaka M, Niisato Y, Kitts DD: Free radical-mediated effects on skeletal muscle protein in rats treated with Fe-nitrilotriacetate. Biochem Biophys Res Commun 231: 37-41, 1997

    Google Scholar 

  31. Markwell MAK, Hass SM, Biebra LL, Tolbert NE: A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 206-210, 1986

    Google Scholar 

  32. Ikeda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, Araki T, Ueda S, Horiuchi S: N ε-(Carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 35: 8075-8083, 1996

    Google Scholar 

  33. Kador PF, Kinoshita JH, Tung WH, Chylack LT Jr: Differences in the susceptibility of various aldose reductases to inhibition. II. Invest Ophthalmol Vis Sci 19: 980-982, 1980

    Google Scholar 

  34. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001

    Google Scholar 

  35. Wohaieb SA, Godin DV: Alterations in free radical tissue defense mechanisms in streptozotocin-induced diabetes in the rat. Effects of insulin treatment. Diabetes 36: 1014-1018, 1987

    Google Scholar 

  36. Sanders RA, Rauscher FM, Watkins JB III: Effects of quercetin on antioxidant defense in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 15: 143-149, 2001

    Google Scholar 

  37. Je HD, Shin CY, Park SY, Yim SH, Kum C, Huh IH, Kim JH, Sohn UD: Combination of vitamin C and rutin on neuropathy and lung damage of diabetes mellitus. Arch Pharm Res 25: 184-190, 2002

    Google Scholar 

  38. Münche G, Keis R, Wessels A, Riederer P, Bahner U, Heidland A, Niwa T, Lemke HD, Schinzel R: Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 35: 669-677, 1997

    Google Scholar 

  39. Miyata T, Taneda S, Kawai R, Ueda Y, Horiuchi S, Hara M, Maeda K, Monnier VM: Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 93: 2353-2358, 1996

    Google Scholar 

  40. Higgins PJ, Bunn HF: Kinetic analysis of the nonenzymatic glycosylation of hemoglobin. J Biol Chem 256: 5204-5208, 1981

    Google Scholar 

  41. Thorpe SR, Baynes JW: Role of the maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging 9: 69-77, 1996

    Google Scholar 

  42. Hammes HD, Boritmann A, Engel L, Wulfroth P: Antioxidant treatment of experimental diabetic retinopathy in rats with nicarnitine. Diabetologia 40: 629-634, 1997

    Google Scholar 

  43. Ramamurthy B, Hook P, Jones AD, Larsson L: Changes in myosin structure and function in response to glycation. FASEB J 15: 2415-2422, 2001

    Google Scholar 

  44. Talasz H, Wasserer S, Puschendorf B: Nonenzymatic glycation of histones in vitro and in vivo. J Cell Biochem 85: 24-34, 2002

    Google Scholar 

  45. Jing H, Kitts DD: Chemical and biochemical properties of casein-sugar Maillard reaction products. Food Chem Toxicol 40: 1007-1015, 2002

    Google Scholar 

  46. Varma DS, Kinoshita JH: Inhibition of lens aldose reductase by flavonoids: Their possible role in the prevention of diabetic cataracts. Biochem Pharmacol 25: 2505-2513, 1976

    Google Scholar 

  47. Day AJ, Dupont MS, Ridley S, Rhodes M, Rhodes MJ, Morgan MR, Williamson G: Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver b-glucosidase activity. FEBS Lett 436: 1-5, 1998

    Google Scholar 

  48. Ioku K, Pongpirouadacha Y, Konishi Y, Takei Y, Nakatani N, Terao J: β-Glucosidase activity in the rat small intestine toward quercetin monoglucosides. Biosci Biotechnol Biochem 62: 1428-1431, 1998.

    Google Scholar 

  49. Spencer JPE, Chowrimootoo G, Choudhury R, Debnam ES, Sarai SK, Rice-Evans C: The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett 458: 224-230, 1999

    Google Scholar 

  50. Andlauer W, Stumpf C, Furst P: Intestinal absorption of rutin in free and conjugated forms. Biochem Pharmacol 62: 369-374, 2001

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nagasawa, T., Tabata, N., Ito, Y. et al. Dietary G-rutin suppresses glycation in tissue proteins of streptozotocin-induced diabetic rats. Mol Cell Biochem 252, 141–147 (2003). https://doi.org/10.1023/A:1025563519088

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1025563519088

Navigation